204 related articles for article (PubMed ID: 9683910)
21. Flow versus uptake comparisons of thallium-201 with technetium-99m perfusion tracers in a canine model of myocardial ischemia.
Meleca MJ; McGoron AJ; Gerson MC; Millard RW; Gabel M; Biniakiewicz D; Roszell NJ; Walsh RA
J Nucl Med; 1997 Dec; 38(12):1847-56. PubMed ID: 9430457
[TBL] [Abstract][Full Text] [Related]
22. Early detection of infarct in reperfused canine myocardium using 99mTc-glucarate.
Okada DR; Johnson G; Liu Z; Hocherman SD; Khaw BA; Okada RD
J Nucl Med; 2004 Apr; 45(4):655-64. PubMed ID: 15073263
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of technetium-99m-Sestamibi and thallium-201 in a transient ischemic myocardium animal model: insight into the 'redistribution' phenomenon.
Mousa SA; Cooney JM; Stevens S
Cardiology; 1992; 81(2-3):157-63. PubMed ID: 1286474
[TBL] [Abstract][Full Text] [Related]
24. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.
Buja LM; Tofe AJ; Kulkarni PV; Mukherjee A; Parkey RW; Francis MD; Bonte FJ; Willerson JT
J Clin Invest; 1977 Sep; 60(3):724-40. PubMed ID: 893676
[TBL] [Abstract][Full Text] [Related]
25. A new method to evaluate ischemic heart disease: combined use of rest thallium-201 myocardial SPECT and Tc-99m exercise tetrofosmin first pass and myocardial SPECT.
Kim Y; Goto H; Kobayashi K; Sawada Y; Miyake Y; Fujiwara G; Okada T; Nishimura T
Ann Nucl Med; 1999 Jun; 13(3):147-53. PubMed ID: 10435374
[TBL] [Abstract][Full Text] [Related]
26. Verapamil does not inhibit 99mTcN-NOET uptake in situ in normal or ischemic canine myocardium.
Riou LM; Ghezzi C; Vanzetto G; Broisat A; Mathieu JP; Bontron R; Pasqualini R; Fagret D
J Nucl Med; 2003 Jun; 44(6):981-7. PubMed ID: 12791829
[TBL] [Abstract][Full Text] [Related]
27. Myocardial kinetics of (201)Thallium, (99m)Tc-tetrofosmin, and (99m)Tc-sestamibi in an acute ischemia-reperfusion model using isolated rat heart.
Fukushima K; Momose M; Kondo C; Kusakabe K; Kasanuki H
Ann Nucl Med; 2007 Jul; 21(5):267-73. PubMed ID: 17634844
[TBL] [Abstract][Full Text] [Related]
28. Technetium-99m-labeled myocardial perfusion agents: Are they better than thallium-201?
Kailasnath P; Sinusas AJ
Cardiol Rev; 2001; 9(3):160-72. PubMed ID: 11304401
[TBL] [Abstract][Full Text] [Related]
29. Assessment of non-reperfused and reperfused myocardial infarction using diffusible or deposited radiolabelled perfusion imaging agents.
Riou LM; Broisat A; Lartizien C; Toufektsian MC; Maitrejean S; Janier M; Vanzetto G; Fagret D; Ghezzi C
Eur J Nucl Med Mol Imaging; 2007 Mar; 34(3):330-7. PubMed ID: 17004095
[TBL] [Abstract][Full Text] [Related]
30. [Identification of viable myocardium using 99mTc-tetrofosmin scintigraphy--comparison with 201Tl redistribution-reinjection images].
Kobayashi H; Kawaguchi M; Oka T; Inoue S; Handa J; Asano R; Matsumoto N; Sumiyoshi T; Hosoda S; Kusakabe K
Kaku Igaku; 1995 Apr; 32(4):367-75. PubMed ID: 7776543
[TBL] [Abstract][Full Text] [Related]
31. Assessment of myocardial viability using 123I-labeled iodophenylpentadecanoic acid at sustained low flow or after acute infarction and reperfusion.
Yang JY; Ruiz M; Calnon DA; Watson DD; Beller GA; Glover DK
J Nucl Med; 1999 May; 40(5):821-8. PubMed ID: 10319757
[TBL] [Abstract][Full Text] [Related]
32. Technetium-99m-labelled HL91 and technetium-99m-labelled MIBI SPECT imaging for the detection of ischaemic viable myocardium: a preliminary study.
Liu M; Ma Z; Guo X; Zhu J; Su J
Clin Physiol Funct Imaging; 2012 Jan; 32(1):25-32. PubMed ID: 22152075
[TBL] [Abstract][Full Text] [Related]
33. Uptake of seven myocardial tracers during increased myocardial blood flow by dobutamine infusion.
Rosenbaum AF; McGoron AJ; Millard RW; Gabel M; Biniakiewicz D; Walsh RA; Gerson MC
Invest Radiol; 1999 Feb; 34(2):91-8. PubMed ID: 9951788
[TBL] [Abstract][Full Text] [Related]
34. Myocardial kinetics of 99m technetium-Q agents: studies in isolated cardiac myocyte, isolated perfused rat heart, and canine regional myocardial ischemia models.
McGoron AJ; Biniakiewicz D; Millard RW; Kumar A; Kennedy SC; Roszell NJ; Gabel M; Huth C; Walsh RA; Gerson MC
Invest Radiol; 1999 Nov; 34(11):704-17. PubMed ID: 10548383
[TBL] [Abstract][Full Text] [Related]
35. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
[TBL] [Abstract][Full Text] [Related]
36. Myocardial redistribution of technetium-99m-methoxyisobutyl isonitrile (SESTAMIBI).
Li QS; Solot G; Frank TL; Wagner HN; Becker LC
J Nucl Med; 1990 Jun; 31(6):1069-76. PubMed ID: 2140856
[TBL] [Abstract][Full Text] [Related]
37. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction.
Koplan BA; Beller GA; Ruiz M; Yang JY; Watson DD; Glover DK
J Nucl Med; 1996 Aug; 37(8):1398-402. PubMed ID: 8708783
[TBL] [Abstract][Full Text] [Related]
38. Comparison of cationic myocardial perfusion agents: characteristics of accumulation in cultured smooth muscle cells.
Nakamura K; Sammiya T; Hashimoto J; Ishibashi R; Matsumoto K; Kubo A
Ann Nucl Med; 1996 Nov; 10(4):375-81. PubMed ID: 9006721
[TBL] [Abstract][Full Text] [Related]
39. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin.
Nakajima K; Taki J; Shuke N; Bunko H; Takata S; Hisada K
J Nucl Med; 1993 Sep; 34(9):1478-84. PubMed ID: 8355067
[TBL] [Abstract][Full Text] [Related]
40. Reliability of technetium-99m Q12 and thallium-201 myocardial activity measurements after triphenyl tetrazolium chloride myocardial staining by perfusion.
Lenihan DJ; McGoron AJ; Gabel M; Walsh RA; Gerson MC
Invest Radiol; 1999 Apr; 34(4):276-81. PubMed ID: 10196719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
